117 related articles for article (PubMed ID: 32366553)
1. Anti-TNF-α Biologics Do Not Reverse CDX2 Downregulation in Patients with Crohn's Disease.
Younes M; Rahimi E; DuPont AW; Ly CJ; Ertan A
Ann Clin Lab Sci; 2020 Mar; 50(2):172-174. PubMed ID: 32366553
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease.
Fang L; Pang Z; Shu W; Wu W; Sun M; Cong Y; Liu Z
Inflamm Bowel Dis; 2018 Jul; 24(8):1733-1744. PubMed ID: 29718341
[TBL] [Abstract][Full Text] [Related]
3. Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.
Verstockt B; Verstockt S; Creyns B; Tops S; Van Assche G; Gils A; Ceuppens JL; Vermeire S; Ferrante M; Breynaert C
Aliment Pharmacol Ther; 2019 Mar; 49(5):572-581. PubMed ID: 30663072
[TBL] [Abstract][Full Text] [Related]
4. TNF-α-induced down-regulation of CDX2 suppresses MEP1A expression in colitis.
Coskun M; Olsen AK; Holm TL; Kvist PH; Nielsen OH; Riis LB; Olsen J; Troelsen JT
Biochim Biophys Acta; 2012 Jun; 1822(6):843-51. PubMed ID: 22326557
[TBL] [Abstract][Full Text] [Related]
5. Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.
Tursi A; Elisei W; Principi M; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E; Brandimarte G
J Gastrointestin Liver Dis; 2014 Sep; 23(3):261-5. PubMed ID: 25267953
[TBL] [Abstract][Full Text] [Related]
6. Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease.
Ringheanu M; Daum F; Markowitz J; Levine J; Katz S; Lin X; Silver J
Inflamm Bowel Dis; 2004 Nov; 10(6):801-10. PubMed ID: 15626899
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA Signatures in the Ileum and Colon of Crohn's Disease Patients and Effect of Anti-TNF-α Treatment on Their Modulation.
Baldan-Martin M; Rubín de Célix C; Orejudo M; Ortega Moreno L; Fernández-Tomé S; Soleto I; Ramirez C; Arroyo R; Fernández P; Santander C; Moreno-Monteagudo JA; Casanova MJ; Casals F; Casabona S; Becerro I; Lozano JJ; Aransay AM; Chaparro M; Gisbert JP
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958675
[TBL] [Abstract][Full Text] [Related]
9. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Van den Brande JM; Koehler TC; Zelinkova Z; Bennink RJ; te Velde AA; ten Cate FJ; van Deventer SJ; Peppelenbosch MP; Hommes DW
Gut; 2007 Apr; 56(4):509-17. PubMed ID: 17082252
[TBL] [Abstract][Full Text] [Related]
10. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.
Juanola O; Moratalla A; Gutiérrez A; Sempere L; Zapater P; Giménez P; Almenta I; Peiró G; González-Navajas JM; Such JF; Francés R
J Gastroenterol; 2015 Jul; 50(7):758-68. PubMed ID: 25500977
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
Zeissig S; Bojarski C; Buergel N; Mankertz J; Zeitz M; Fromm M; Schulzke JD
Gut; 2004 Sep; 53(9):1295-302. PubMed ID: 15306588
[TBL] [Abstract][Full Text] [Related]
12. Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.
Biancheri P; Di Sabatino A; Rovedatti L; Giuffrida P; Calarota SA; Vetrano S; Vidali F; Pasini A; Danese S; Corazza GR; MacDonald TT
Inflamm Bowel Dis; 2013 Feb; 19(2):259-64. PubMed ID: 23328772
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
[TBL] [Abstract][Full Text] [Related]
14. Hyperresponsiveness of the mucosal barrier in Crohn's disease is not tumor necrosis factor-dependent.
Suenaert P; Bulteel V; Vermeire S; Noman M; Van Assche G; Rutgeerts P
Inflamm Bowel Dis; 2005 Jul; 11(7):667-73. PubMed ID: 15973122
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Shanahan F
Inflamm Bowel Dis; 2000 May; 6(2):137-9. PubMed ID: 10833074
[No Abstract] [Full Text] [Related]
16. Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy.
Leal RF; Planell N; Kajekar R; Lozano JJ; Ordás I; Dotti I; Esteller M; Masamunt MC; Parmar H; Ricart E; Panés J; Salas A
Gut; 2015 Feb; 64(2):233-42. PubMed ID: 24700437
[TBL] [Abstract][Full Text] [Related]
17. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Laminin γ2 Expression by CDX2 in Colonic Epithelial Cells Is Impaired During Active Inflammation.
Coskun M; Soendergaard C; Joergensen S; Dahlgaard K; Riis LB; Nielsen OH; Sandelin A; Troelsen JT
J Cell Biochem; 2017 Feb; 118(2):298-307. PubMed ID: 27333824
[TBL] [Abstract][Full Text] [Related]
19. Transcending conventional therapies: the role of biologic and other novel therapies.
Sandborn WJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CDX2 in the cross talk between TNF-α and Wnt signaling pathway in the colon cancer cell line Caco-2.
Coskun M; Olsen AK; Bzorek M; Holck S; Engel UH; Nielsen OH; Troelsen JT
Carcinogenesis; 2014 May; 35(5):1185-92. PubMed ID: 24501326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
